In conclusion, this meta‐analysis suggests that once‐weekly insulin in Type 1 Diabetes Mellitus offers a nuanced alternative to daily insulin, with modest differences in glycemic control and notable safety considerations. The gene discussed is INS; the disease is type 1 diabetes mellitus.